FDA News
🇺🇸 FDA Page 4FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 37–48 of 391 articles
FDA approves Dupixent for COPD with eosinophilic phenotype
FDA · chronic obstructive pulmonary disease · 6 min
Dr. Sarah MitchellGSK Blenrep wins FDA approval in relapsed multiple myeloma
FDA · blood cancer · 6 min
Dr. Sarah MitchellFDA Approves Vertex’s First-in-Class Non-Opioid Pain Drug Journavx
FDA · moderate-to-severe acute pain · 8 min
Dr. Sarah MitchellFDA approves Keytruda for adjuvant NSCLC treatment, expanding Merck’s lung cancer label
FDA · lung cancer · 6 min
Dr. Sarah MitchellFDA approves Merck’s Keytruda for adjuvant NSCLC treatment
FDA · lung cancer · 8 min
Dr. Sarah MitchellEli Lilly's donanemab wins FDA approval for early Alzheimer's disease
FDA · Alzheimer's disease · 6 min
Dr. Sarah MitchellFDA approves Keytruda for adjuvant NSCLC, a Merck catalyst
FDA · lung cancer · 7 min
Dr. Sarah MitchellVertex launches Journavx after FDA approval for acute pain
FDA · oncology · 9 min
Dr. Sarah MitchellFDA approves Keytruda adjuvant NSCLC use in early-stage lung cancer
FDA · oncology · 7 min
Dr. Sarah MitchellFDA approves Keytruda adjuvant NSCLC use: what Merck investors should watch
FDA · oncology · 7 min
Dr. Sarah MitchellGene Therapy FDA Approval for Rare Disease: Updated List and Analysis
FDA · rare disease · 5 min
Dr. Sarah MitchellExclusive: FDA issues industry-friendly gene therapy guidance: What BD teams need to know
FDA · gene therapy · 4 min
Dr. Sarah MitchellExplore intelligence